KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Other Operating Expenses (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Other Operating Expenses for 7 consecutive years, with $472.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses rose 55.0% year-over-year to $472.1 million, compared with a TTM value of $1.4 billion through Dec 2025, up 52.4%, and an annual FY2023 reading of $1.3 billion, down 64.77% over the prior year.
  • Other Operating Expenses was $472.1 million for Q3 2025 at Clover Health Investments, down from $488.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $950.8 million in Q4 2022 and bottomed at -$242.0 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is $522.2 million, with a median of $494.1 million recorded in 2023.
  • The sharpest move saw Other Operating Expenses soared 24688.19% in 2021, then tumbled 125.45% in 2023.
  • Year by year, Other Operating Expenses stood at $618.8 million in 2021, then soared by 53.64% to $950.8 million in 2022, then crashed by 125.45% to -$242.0 million in 2023, then surged by 225.87% to $304.6 million in 2024, then skyrocketed by 55.0% to $472.1 million in 2025.
  • Business Quant data shows Other Operating Expenses for CLOV at $472.1 million in Q3 2025, $488.2 million in Q2 2025, and $463.6 million in Q1 2025.